Neoplasms of the mediastinum, chest wall, and pleura

Research output: Contribution to journalReview article

Abstract

Although primary malignant diseases of the mediastinum, chest wall, and pleura are rare, the interest in investigational activity in mesothelioma and thymoma has increased because of new technologies such as magnetic resonance imaging, monoclonal antibody testing, thoracoscopy, and genetic engineering. Improvement in treatment outcome among patients with mesothelioma has been slow, due in part to the rarity of the disease and in part to resistance to treatment. Groupwide or intergroup studies are needed to assess the biology and treatment of these disorders. Advanced malignant thymoma has been shown to be sensitive to chemotherapy. Active studies to define the optimal treatment regimen continue.

Original languageEnglish (US)
Pages (from-to)171-176
Number of pages6
JournalCurrent opinion in oncology
Volume6
Issue number2
DOIs
StatePublished - Jan 1 1994
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this